Tripeptide Tyroserleutide Plus Doxorubicin: Therapeutic Synergy and Side Effect Attenuation

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-8-342
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC